VJHemOnc Podcast cover image

iwAL 2023 Session IV: Transplantation and immunotherapies in AML: improving patient outcomes

VJHemOnc Podcast

CHAPTER

Targeting Pre-Transplant MRT for Improved AML Patient Outcomes

This chapter discusses the potential of targeting pre transplant minimal residual disease (MRT) in AML patients to reduce relapse and improve transplant outcomes. They emphasize the lack of clinical trials in this area and the importance of standardizing MRT assays for the benefit of patients and the development of new therapies.

00:00
Transcript
Play full episode

Remember Everything You Learn from Podcasts

Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
App store bannerPlay store banner